News
- Author:
- Neil Osterweil
Publish date: September 19, 2022
People should be made aware of these links and try to make lifestyle changes to reduce their risk of OSA.
News
- Author:
- Neil Osterweil
Publish date: September 19, 2022
Patients typically excluded from clinical trials because of age or comorbidities had better survival with atezolizumab than single-agent chemothera...
News
- Author:
- Neil Osterweil
Publish date: September 19, 2022
Objective responses, not time-dependent survival outcomes, should be endpoints for single-arm trials, with results only used for conditional approv...
News
- Author:
- Neil Osterweil
Publish date: September 15, 2022
“Until now there had been no direct comparison of the two to inform decision-making.”
News
- Author:
- Neil Osterweil
Publish date: September 14, 2022
Some trends favored chemoradiation plus pembrolizumab over chemoradiation alone, but KEYNOTE-412 failed to meet primary endpoint.
News
- Author:
- Neil Osterweil
Publish date: September 14, 2022
The finding could lead to strategies for preventing lung cancer in nonsmokers exposed to high levels of foul air.
News
- Author:
- Neil Osterweil
Publish date: September 7, 2022
“A personalized endotype-based treatment with oral prednisolone is possible in patients with COPD.”
News
- Author:
- Neil Osterweil
Publish date: September 7, 2022
Bronchodilator therapy was no better than placebo at reducing respiratory symptoms in smokers without airway obstruction.
News
- Author:
- Neil Osterweil
Publish date: August 29, 2022
Regardless of the whole breast irradiation fractionation schedule, a 16 Gy tumor-bed boost halved the risk of DCIS recurrence at 5 years.
News
- Author:
- Neil Osterweil
Publish date: August 29, 2022
There were no differences in efficacy for patients treated with radiation plus concurrent chemoradiation vs. radiation alone in a randomized trial....
News
- Author:
- Neil Osterweil
Publish date: August 11, 2022
A study of women with lung cancer who never smoked suggests that air pollution may be a larger risk factor for lung cancer than currently understoo...
News
- Author:
- Neil Osterweil
Publish date: August 11, 2022
Offering smoking cessation support at the time and place of lung cancer screening resulted in high smoking abstinence rates at 1 year.
News
- Author:
- Neil Osterweil
Publish date: August 9, 2022
The trial was halted early due to excess deaths in the surgery arm before type of optimal deescalation therapy could be answered.
News
- Author:
- Neil Osterweil
Publish date: August 2, 2022
Every 10% increase in stromal tumor-infiltrating lymphocytes was associated with a 19% reduction in the risk of death.
News
- Author:
- Neil Osterweil
Publish date: July 13, 2022
Time to diagnosis of metastatic cancer increased by nearly 5 months for patients whose employers switched them to high-deductible health insurance ...
